Sabra Health Care REIT (SBRA) EBIT (2016 - 2026)

Sabra Health Care REIT's EBIT history runs 11 years deep, the most recent figure standing at $67.8 million for Q1 2026.

• In Q1 2026, EBIT changed 0.34% year-over-year to $67.8 million; the TTM figure through Mar 2026 stood at $266.1 million (up 4.24% YoY), while the FY2025 annual figure was $265.9 million, up 9.25% from the prior year.
• EBIT was $67.8 million for Q1 2026 at Sabra Health Care REIT, up from $54.9 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $92.8 million in Q2 2025 to a low of -$18.0 million in Q3 2022.
• Historically, EBIT has averaged $49.2 million across 5 years, with a median of $53.6 million in 2024.
• The sharpest annual moves came in 2022 and 2024: EBIT plunged 146.79% in 2022, then surged 315.46% in 2024.
• A 5-year view of EBIT shows it stood at $31.4 million in 2022, then soared by 47.73% to $46.4 million in 2023, then jumped by 62.31% to $75.3 million in 2024, then dropped by 27.01% to $54.9 million in 2025, then grew by 23.46% to $67.8 million in 2026.
• The last three EBIT figures came in at $67.8 million (Q1 2026), $54.9 million (Q4 2025), and $50.6 million (Q3 2025), per Business Quant data.